Back

Troponin/creatine kinase ratio for discrimination of type 1 and type 2 myocardial infarction

31 August 2024 (08:15 - 08:27)
Organised by: Logo
Congress Presentation Part of: High-sensitivity cardiac troponin assays: integrating evidence from clinical trials and implementation studies Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jonas Lehmacher

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

4 More presentations in this session

Presentation thumbnail
Rapid rule-out of acute myocardial infarction using the 0/1-hour algorithm for cardiac troponins in emergency primary care: the OUT-ACS implementation study.
Doctor T. Johannessen (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Clinical and experimental evidence for differences between cardiac troponin I and T in acute and chronic cardiovascular conditions
Doctor T. Zimmermann (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Serial troponin sampling over 60-minutes allows early distinction between myocardial infarction and chronic myocardial injury in patients presenting to emergency departments.
Miss G. Vimalaratnam (AU)
Abstract Slides Video
Presentation thumbnail
Acute kidney injury in relation to high-sensitivity cardiac troponin T levels in the emergency department
Doctor L. Cyon (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
High-sensitivity cardiac troponin assays: integrating evidence from clinical trials and implementation studies
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 08:15 CET
You may be interested in
thumbnail
Congress Session
High-sensitivity cardiac troponin assays: integrating evidence from clinical trials and implementation studies
thumbnail
Congress Presentation
The use of biomarkers to identify and prognosticate patients with a type 2 myocardial infarction (T2MI): a systematic review
thumbnail
Congress Presentation
Clinical and experimental evidence for differences between cardiac troponin I and T in acute and chronic cardiovascular conditions

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources